HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

7-cysteaminomitosane

structure given in first source

Also Known As:

RR 150; RR-150

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Quinones: 434
  - Indolequinones: 12
    - Mitomycins: 11
      - 7-cysteaminomitosane: 3
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azirines
    - Mitomycins: 11
      - 7-cysteaminomitosane: 3
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indolequinones: 12
        Mitomycins: 11
        7-cysteaminomitosane: 3

Experts

1.	Ecker, J: 1 article (01/2002)

Related Diseases

1.	Leukemia P388 02/01/1988 - "7-Cysteaminomitosane (RR-150) has been reported to be superior to mitomycin C against P388 leukemia and B-16 melanoma in mice and is less leukopenic. " 12/01/1984 - "to mice bearing i.p.-implanted tumors, RR-150 was superior to mitomycin C (MMC) in increasing the life span of animals bearing P388 leukemia, B16 melanoma, and a line of L1210 leukemia partially resistant to MMC. "
2.	Overweight 01/01/2002 - "In overweight (BMI > 28 kg/m2) subjects, whose percentage in our population were 32%, blood pressure was elevated (RR > 150/90) in 51%. "
3.	Neoplasms (Cancer) 12/01/1984 - "RR-150 had inconsistent activity in the treatment of s.c.-implanted tumors. " 12/01/1984 - "to mice bearing i.p.-implanted tumors, RR-150 was superior to mitomycin C (MMC) in increasing the life span of animals bearing P388 leukemia, B16 melanoma, and a line of L1210 leukemia partially resistant to MMC. "
4.	Experimental Melanoma 12/01/1984 - "to mice bearing i.p.-implanted tumors, RR-150 was superior to mitomycin C (MMC) in increasing the life span of animals bearing P388 leukemia, B16 melanoma, and a line of L1210 leukemia partially resistant to MMC. "
5.	Melanoma (Melanoma, Malignant) 02/01/1988 - "7-Cysteaminomitosane (RR-150) has been reported to be superior to mitomycin C against P388 leukemia and B-16 melanoma in mice and is less leukopenic. "

Related Drugs and Biologics

1.	Mitomycin (Mitomycin-C)